INKT — MiNK Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-10-15.
Performance
Technicals
Others in Healthcare
Measured signals that fired on INKT
| date | signal | measured base rate |
|---|---|---|
| 2026-04-24 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-03-19 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-04 | Ryan Barbara Director | Open-market sale | 1.0K | 12.80 | 12.8K |
| 2026-06-04 | Ryan Barbara Director | Open-market sale | 500 | 12.68 | 6.3K |
| 2026-06-01 | Corvese Brian Director | Grant or award | 1.4K | 12.38 | 17.9K |
| 2026-06-01 | Ryan Barbara Director | Grant or award | 1.4K | 12.38 | 17.8K |
| 2026-06-01 | Behner Peter Director | Grant or award | 1.3K | 12.38 | 16.3K |
| 2026-06-01 | WIINBERG ULF Director | Grant or award | 1.1K | 12.38 | 14.0K |
| 2026-06-01 | Holcomb John Bradley Director | Grant or award | 1.1K | 12.38 | 13.5K |
| 2026-03-10 | Ryan Barbara Director | Open-market sale | 500 | 15.57 | 7.8K |
| 2026-03-10 | Ryan Barbara Director | Open-market sale | 500 | 15.30 | 7.7K |
| 2026-03-10 | Ryan Barbara Director | Open-market sale | 300 | 15.28 | 4.6K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 625.1K | 59.4K |
| GEODE CAPITAL MANAGEMENT, LLC | 182.7K | 17.3K |
| Longbow Finance SA | 175.5K | 16.7K |
| UBS Group AG | 160.1K | 15.2K |
| VANGUARD FIDUCIARY TRUST CO | 87.3K | 8.3K |
| BlackRock, Inc. | 65.3K | 6.2K |
| Steward Partners Investment Advisory, LLC | 21.1K | 2.0K |
| Annis Gardner Whiting Capital Advisors, LLC | 2.1K | 200 |
| Tower Research Capital LLC (TRC) | 1.6K | 156 |
| MORGAN STANLEY | 1.1K | 104 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Mink Therapeutics, Inc. (INKT) filed form 8-K · 2026-08-13 · SEC EDGAR
Ask the AI about INKT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →